Early Goal-Directed Therapy With and Without Intermittent Superior Vena Cava Oxygen Saturation Monitoring in Pediatric Septic Shock: A Randomized Controlled Trial

2021 ◽  
Vol 58 (12) ◽  
pp. 1124-1130
Author(s):  
Puneet Jain ◽  
Ramachandran Rameshkumar ◽  
Ponnarmeni Satheesh ◽  
Subramanian Mahadevan
2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Glenn Hernández ◽  
◽  
Alexandre Biasi Cavalcanti ◽  
Gustavo Ospina-Tascón ◽  
Fernando Godinho Zampieri ◽  
...  

Shock ◽  
2009 ◽  
Vol 31 (6) ◽  
pp. 562-568 ◽  
Author(s):  
Petros Kopterides ◽  
Stefanos Bonovas ◽  
Irini Mavrou ◽  
Eleni Kostadima ◽  
Epaminondas Zakynthinos ◽  
...  

2020 ◽  
Author(s):  
Walid S. Alhabashy ◽  
Osama M. Shalaby ◽  
Ahmed S. Elgebaly ◽  
Mohammed S. Abd El Ghafar

Abstract Background: Echocardiography (ECHO) is used to guide septic shock resuscitation, but without evidence for efficacy. Therefore, we compared the outcome of early goal-directed therapy (EGDT) and ECHO-guided management of hemodynamics in severe sepsis and septic shock. Materials and Methods: This is a single center, randomized controlled trial conducted on 100 adult patients with severe sepsis or septic shock. Patients were assessed and treated with either EGDT protocol (EGDT group) or ECHO-guided resuscitation protocol (ECHO group). Results: Only 87 patients (45 in group I and 42 in group II) were analyzed. There was a significant increase of mean norepinephrine and dobutamine doses and a significant decrease in total fluids in the first 24 hours, time to normalization, time to weaning of vasopressors, total MV days, MV free days and ICU and hospital stays in ECHO group. At 30 days, the mortality rate in EGDT group was 35.6% which was significantly higher compared to 14.3% in ECHO group. At 90 days, the overall mortality was significantly higher in EGDT group compared to Echo group (40.0% vs 16.7% respectively). Hazardous ratio of mortality was 1.630 (95% confidence interval (CI): 1.123 - 2.366) and 1.653 (95% CI: 1.137 - 2.404) at 30 and 90 days respectively in EGDT group compared to ECHO group. Conclusions: In severe sepsis and septic shock, ECHO-guided management of hemodynamics resulted in a decrease in mortality, lower total fluid intake, higher vasopressor and inotrope support, earlier weaning of vasopressors and less MV days, ICU and hospital stay.


Critical Care ◽  
2009 ◽  
Vol 13 (Suppl 1) ◽  
pp. P235
Author(s):  
P Kopterides ◽  
I Mavrou ◽  
E Kostadima ◽  
E Zakynthinos ◽  
M Lignos ◽  
...  

2016 ◽  
Vol 32 (10) ◽  
pp. 567-573
Author(s):  
Lindsay Lief ◽  
John Arbo ◽  
David A. Berlin

In 2001, Rivers and colleagues published a randomized controlled trial of early goal-directed therapy (EGDT) for the treatment of sepsis. More than a decade later, it remains a landmark achievement. The study proved the benefits of early aggressive treatment of sepsis. However, many questions remain about specific aspects of the complex EGDT algorithm. Recently, 3 large trials attempted to replicate these results. None of the studies demonstrated a benefit of an EGDT protocol for sepsis. This review explores the physiologic basis of goal-directed therapy, including the hemodynamic targets and the therapeutic interventions. An understanding of the physiologic basis of EGDT helps reconcile the results of the clinical trials.


2020 ◽  
Author(s):  
Walid S. Alhabashy ◽  
Osama M. Shalaby ◽  
Ahmed S. Elgebaly ◽  
Mohammed S. Abd El Ghafar

Abstract Background: Echocardiography (ECHO) is used to guide septic shock resuscitation, but without evidence for efficacy. Therefore, we compared the outcome of early goal-directed therapy (EGDT) and ECHO-guided management of hemodynamics in severe sepsis and septic shock. Methods: This is a single canter, randomized controlled trial conducted on 100 adult patients with severe sepsis or septic shock. Patients were assessed and treated either EGDT protocol (EGDT group) or ECHO-guided resuscitation protocol (ECHO group). Results: In this study, only 87 patients with severe sepsis/septic shock were analyzed; 45 patients in group I and 42 patients in group II. There was significant increase of norepinephrine, dobutamine doses, MV free days, time to normalization, time to weaning of vasopressors, total MV days and ICU and hospital stay in EGDT group compared to ECHO group. At 30 days, the mortality rate in EGDT group was 35.6% which was significantly higher compared to 14.3% in ECHO group. At 90 days, the overall mortality was significantly higher in EGDT group compared to Echo group (40.0% vs 16.7% respectively). Hazardous ratio of mortality was 1.630 (95% confidence interval (CI): 1.123 - 2.366) and 1.653 (95% CI: 1.137 - 2.404) at 30 and 90 days respectively in EGDT group compared to ECHO group.Conclusion: In severe sepsis and septic shock, ECHO-guided management of hemodynamic resulted in decrease in mortality, lower total fluid intake, vasopressor and inotrope, earlier weaning of vasopressors and less MV days, ICU and hospital stay.


Sign in / Sign up

Export Citation Format

Share Document